Scientists test new drug duo to boost lung cancer treatment
Disease control
Completed
This small, early-stage study tested whether adding a new drug called copanlisib to an existing immunotherapy (durvalumab) could help patients with a specific type of advanced lung cancer. The main goal was to find a safe dose for the drug combination and see if it could help the…
Phase: PHASE1 • Sponsor: Zhonglin Hao • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC